Number 70

Turning more than one page

Editorial 5 January 2016 0

We at ESO are turning important pages in the history of our service to the European cancer community. We now invite you to turn the pages of Cancer World, which we hope you will find [more]

We at ESO are turning important pages in the history of our service to the European cancer community. We now invite you to turn the pages of Cancer World, which we hope you will find both an informative and enjoyable read.... [ more ]

Tipping the balance

Cover Story, Featured 5 January 2016 0

Almost four in ten serious adverse drug reactions now listed in the labels of 12 targeted cancer therapies were not mentioned in the studies that led to their approval. Half the serious reactions that were [more]

Almost four in ten serious adverse drug reactions now listed in the labels of 12 targeted cancer therapies were not mentioned in the studies that led to their approval. Half the serious reactions that were missed are potentially f... [ more ]

A strategic moment

Cutting Edge 5 January 2016 0

New knowledge favours promoting peace over waging war The world spends billions on trench warfare with cancer and makes slow progress with heavy collateral damage. New knowledge about the process of carcinogenesis and tumour growth [more]

The world spends billions on trench warfare with cancer and makes slow progress with heavy collateral damage. New knowledge about the process of carcinogenesis and tumour growth is now fuelling calls for a change of strategy to fo... [ more ]

Fedro Peccatori: teaching the world to care

Profile 5 January 2016 0

First he was a pupil, then he joined the faculty. Now Fedro Peccatori has taken charge of ESO’s entire educational programme, and he knows exactly where he wants to take it. “There is no difference [more]

First he was a pupil, then he joined the faculty. Now Fedro Peccatori has taken charge of ESO’s entire educational programme, and he knows exactly where he wants to take it.... [ more ]

Unleashing the potential of prevention

Featured, Spotlight on 5 January 2016 0

The revised European Cancer Code, launched last October, gives clear and concise information on what people can do to lower their own cancer risk. But until policy makers – and doctors – take prevention more [more]

The revised European Cancer Code, launched last October, gives clear and concise information on what people can do to lower their own cancer risk. But until policy makers – and doctors – take prevention more seriously, millions of... [ more ]

Multiparametric MRI in prostate cancer

Featured, Grandround 5 January 2016 0

This egrandround was first presented by Caroline Moore, from University College Hospital London, as a live webcast for the European School of Oncology. It is edited by Susan Mayor. The webcast of this and other [more]

Traditionally confined to a role in staging, MRI is increasingly being used along the entire continuum from diagnosis to care and follow up in patients with prostate cancer.... [ more ]

A journey to the heart of the EMA

Featured, Patient Voice 5 January 2016 0

Flexibility and goodwill have allowed patient involvement in the work of Europe’s drug regulators to develop at an impressive pace. But will they be enough to withstand the strains on the relationship exerted by financial [more]

Flexibility and goodwill have allowed patient involvement in the work of Europe’s drug regulators to develop at an impressive pace. But will they be enough to withstand the strains on the relationship exerted by financial pressure... [ more ]

The road to global cancer care

Highlight, Our World 5 January 2016 0

The world is experiencing new and powerful forces in global health, from the Sustainable Development Goals, and ‘grand convergences’ to what is now the central totem in global health – universal health coverage. For cancer [more]

The world is experiencing new and powerful forces in global health, from the Sustainable Development Goals, and ‘grand convergences’ to what is now the central totem in global health – universal health coverage. For cancer control... [ more ]

Bridging the gap in metastatic breast cancer

Spotlight on 5 January 2016 0

Every two years the metastatic breast cancer community convenes to assess what needs to be done to bridge gaps – gaps in scientific/clinical knowledge and in service provision, and gaps between the patients and professional [more]

Every two years the metastatic breast cancer community convenes to assess what needs to be done to bridge gaps – gaps in scientific/clinical knowledge and in service provision, and gaps between the pa... [ more ]

Cognitive effects of endocrine therapy

Impact Factor 5 January 2016 1

The impact chemotherapy can have on the ability to think clearly is well recognised. Less is known, however, about the cognitive effect of endocrine therapies, which in the adjuvant breast cancer setting are being prescribed [more]

The impact chemotherapy can have on the ability to think clearly is well recognised. Less is known, however, about the cognitive effect of endocrine therapies, which in the adjuvant breast cancer setting are being prescribed for u... [ more ]